Tuesday, April 23, 2024

UTSA receives $6.8M in NIH funding to establish research center targeting valley fever

UTSA receives $6.8M in NIH funding to establish research center targeting valley fever

Chiung-Yu Hung, associate professor in the UTSA Department of Molecular Microbiology and Immunology, will lead UTSA mycology and immunology researchers in the establishment of a research center developing therapeutics and vaccines against valley fever. A five-year, $6.8 million grant from the National Institutes of Health will support this effort.

FEBRUARY 8, 2022 — Mycology and immunology researchers from The University of Texas at San Antonio have been selected to receive a five-year, $6.8 million grant from the National Institutes of Health to establish a San Antonio-based Coccidioidomycosis Collaborative Research Center (SA-CCRC) focused on developing therapeutics and vaccines against coccidioidomycosis. This highly interactive, interdisciplinary research hub will support the collaborative efforts of investigators from UTSA and UT Health San Antonio.

"The award is a testament to the caliber of the mycology research group and the established expertise in innovative solutions for vaccine development against infectious diseases at UTSA," said Bernard Arulanandam, UTSA vice president for Research, Economic Development, and Knowledge Enterprise.

Coccidioidomycosis, also known as valley fever, is a respiratory fungal infection found in the Southwestern United States and some aerial regions in Central and South America. Infection occurs by breathing in microscopic spores from the air in environments where the fungus Coccidioides resides.


“(Dr. Hung's team) exemplifies how UTSA researchers are tackling real-world challenges to meet an ever-growing critical need.”



There are an estimated 380,000 new cases in the U.S. each year. This fungal infection can lead to a broad spectrum of disorders, from self-limited flu-like symptoms to progressive pulmonary destruction and life-threatening meningitis if dissemination occurs.

The SA-CCRC will support applied clinical research and will also house an extended network of experts and collaborators from partnering institutions across the nation. Members of the center will include seasoned investigators with knowledge and technical expertise in coccidioidomycosis as well as emerging researchers attracted to this area of medical mycology.

Chiung-Yu Hung, associate professor in the UTSA Department of Molecular Microbiology and Immunology, is a research expert in the field of Coccidioides. Her experience ranges from the development of therapeutics, diagnostics and vaccines against Coccidioides infections. She has also used multidisciplinary approaches, including molecular biology, cellular biology and immunological techniques to study host-pathogen interactions.

“Currently there is no FDA-approved vaccine against this respiratory fungal infection and approximately one-third of clinical isolates of Coccidioides species display in vitro resistance to commonly used antifungal drugs such as fluconazole,” Hung said. “There is an urgent and unmet need to develop better and safe therapeutic drugs and a human vaccine to prevent this fungal disease that can sometimes spread beyond the lungs to other vital organs including the skin, bone, liver, heart and brain.”

“Dr. Hung, along with the team she has assembled, exemplifies how UTSA researchers are tackling real-world challenges to meet an ever-growing critical need,” Arulanandam added.

Hung will lead a research team in the center that seeks to develop a human vaccine with recombinant antigen and mRNA technologies. The team will study protective immunity measures against coccidioidomycosis. Joining Hung is Jose Lopez-Ribot, a faculty member in the UTSA College of Sciences with more than 30 years of experience in the field of medical mycology and co-PI of the NIH grant.

“San Antonio has a rich tradition of excellence in the study of fungal infections, with a large and highly cooperative group of medical mycologists,” Lopez-Ribot said. “We are honored to have been selected by NIH to establish this collaborative Center to advance research and treatment, and to train the next generation of scientists on these devastating infections.”

The center’s members will include faculty members Astrid Cardona, Brian Hermann, Soo-Chan Lee, Karl Klose, Stephen Saville, Yufeng Wang and Jieh-Juen Yu from UTSA; Thomas F. Patterson and Nathan Wiederhold from UT Health San Antonio; George Thompson from UC Davis; and Gary Ostroff from the University of Massachusetts Chan Medical School.

“We have worked with Lopez-Ribot and Hung on developing new treatments for coccidioidomycosis and look forward to continuing this important collaboration,” said Patterson, professor and chief of infectious diseases in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio. Patterson is also the director of the San Antonio Center for Medical Mycology.

“Coccidioidomycosis is an important fungal pathogen in the U.S. Southwest including San Antonio, and can cause devastating infections, including meningitis, that currently require lifelong therapy,” Patterson added. “Wiederhold and his colleagues in the Fungus Testing Laboratory at UT Health San Antonio have shown that resistance of Coccidioides to frequently used antifungal medications is common, so that development of new therapies and approaches such as vaccines are critically needed.”

Ryan Schoensee



UTSA Today is produced by University Strategic Communications,
the official news source
of The University of Texas at San Antonio.

Send your feedback to news@utsa.edu.


UTSA Today is produced by University Communications and Marketing, the official news source of The University of Texas at San Antonio. Send your feedback to news@utsa.edu. Keep up-to-date on UTSA news by visiting UTSA Today. Connect with UTSA online at Facebook, Twitter, Youtube and Instagram.


Spotlight

Spotlight

dtc-utsa-sign_680.png
University of Texas at San Antonio receives ‘transformational’ $40M gift

UTSA’s Mission

The University of Texas at San Antonio is dedicated to the advancement of knowledge through research and discovery, teaching and learning, community engagement and public service. As an institution of access and excellence, UTSA embraces multicultural traditions and serves as a center for intellectual and creative resources as well as a catalyst for socioeconomic development and the commercialization of intellectual property - for Texas, the nation and the world.

UTSA’s Vision

To be a premier public research university, providing access to educational excellence and preparing citizen leaders for the global environment.

UTSA’s Core Values

We encourage an environment of dialogue and discovery, where integrity, excellence, inclusiveness, respect, collaboration and innovation are fostered.

UTSA’S Destinations

UTSA is a proud Hispanic Serving Institution (HSI) as designated by the U.S. Department of Education .

Our Commitment to Inclusivity

The University of Texas at San Antonio, a Hispanic Serving Institution situated in a global city that has been a crossroads of peoples and cultures for centuries, values diversity and inclusion in all aspects of university life. As an institution expressly founded to advance the education of Mexican Americans and other underserved communities, our university is committed to promoting access for all. UTSA, a premier public research university, fosters academic excellence through a community of dialogue, discovery and innovation that embraces the uniqueness of each voice.